And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been assessed in America and Britain, not everyone is convinced.
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...